Interest of preoperative immunonutrition in liver resection for cancer: study protocol of the PROPILS trial, a multicenter randomized controlled phase IV trial

Oriana Ciacio, Thibault Voron, Gabriella Pittau, Maité Lewin, Eric Vibert, René Adam, Antonio Sa Cunha, Daniel Cherqui, Astrid Schielke, Olivier Soubrane, Olivier Scatton, Chady Salloum, Daniel Azoulay, Stéphane Benoist, Perrine Goyer, Jean-Christophe Vaillant, Laurent Hannoun, Emmanuel Boleslawski, Hélène Agostini, Didier Samuel, Denis Castaing, Oriana Ciacio, Thibault Voron, Gabriella Pittau, Maité Lewin, Eric Vibert, René Adam, Antonio Sa Cunha, Daniel Cherqui, Astrid Schielke, Olivier Soubrane, Olivier Scatton, Chady Salloum, Daniel Azoulay, Stéphane Benoist, Perrine Goyer, Jean-Christophe Vaillant, Laurent Hannoun, Emmanuel Boleslawski, Hélène Agostini, Didier Samuel, Denis Castaing

Abstract

Background: Malnutrition is an independent risk factor of postoperative morbidity and mortality and it's observed in 20 to 50% of surgical patients. Preoperative interventions to optimize the nutritional status, reduce postoperative complications and enteral nutrition has proven to be superior to the parenteral one. Moreover, regardless of the nutritional status of the patient, surgery impairs the immunological response, thus increasing the risk of postoperative sepsis. Immunonutrition has been developed to improve the immunometabolic host response in perioperative period and it has been proven to reduce significantly postoperative infectious complications and length of hospital stay in patients undergoing elective gastrointestinal surgery for tumors. We hypothesize that a preoperative oral immunonutrition (ORAL IMPACT®) can reduce postoperative morbidity in liver resection for cancer.

Methods/design: Prospective multicenter randomized placebo-controlled double-blind phase IV trial with two parallel treatment groups receiving either study product (ORAL IMPACT®) or control supplement (isocaloric isonitrogenous supplement--IMPACT CONTROL®) for 7 days before liver resection for cancer. A total of 400 patients will be enrolled. Patients will be stratified according to the type of hepatectomy, the presence of chronic liver disease and the investigator center. The main end-point is to evaluate in intention-to-treat analysis the overall 30-day morbidity. Secondary end-points are to assess the 30-day infectious and non-infectious morbidity, length of antibiotic treatment and hospital stay, modifications on total food intake, compliance to treatment, side-effects of immunonutrition, impact on liver regeneration and sarcopenia, and to perform a medico-economic analysis.

Discussion: The overall morbidity rate after liver resection is 22% to 42%. Infectious post-operative complications (12% to 23%) increase the length of hospital stay and costs and are responsible for a quarter of 30-day mortality. Various methods have been advocated to decrease the rate of postoperative complications but there is no evidence to support or refute the use of any treatment and further trials are required. The effects of preoperative oral immunonutrition in non-cirrhotic patients undergoing liver resection for cancer are unknown. The present trial is designed to evaluate whether the administration of a short-term preoperative oral immunonutrition can reduce postoperative morbidity in non-cirrhotic patients undergoing liver resection for cancer.

Trial registration: Clinicaltrial.gov: NCT02041871.

Figures

Figure 1
Figure 1
Schema depicting the workflow of the study.

References

    1. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191:38–46. doi: 10.1016/S1072-7515(00)00261-1.
    1. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002;236:397–406. doi: 10.1097/00000658-200210000-00001.
    1. Adam R, Aloia T, Krissat J, Bralet M-P, Paule B, Giacchetti S, Delvart V, Azoulay D, Bismuth H, Castaing D. Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg. 2006;244:897–907. doi: 10.1097/01.sla.0000246847.02058.1b.
    1. Adam R, Chiche L, Aloia T, Elias D, Salmon R, Rivoire M, Jaeck D, Saric J, Le Treut YP, Belghiti J, Mantion G, Mentha G. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg. 2006;244:524–535. doi: 10.1097/01.sla.0000246847.02058.1b.
    1. Finch RJB, Malik HZ, Hamady ZZR, Al-Mukhtar A, Adair R, Prasad KR, Lodge JPA, Toogood GJ. Effect of type of resection on outcome of hepatic resection for colorectal metastases. Br J Surg. 2007;94:1242–1248. doi: 10.1002/bjs.5640.
    1. Farid SG, Aldouri A, Morris-Stiff G, Khan AZ, Toogood GJ, Lodge JPA, Prasad KR. Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg. 2010;251:91–100. doi: 10.1097/SLA.0b013e3181bfda3c.
    1. Ito H, Are C, Gonen M, D’Angelica M, Dematteo RP, Kemeny NE, Fong Y, Blumgart LH, Jarnagin WR. Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg. 2008;247:994–1002. doi: 10.1097/SLA.0b013e31816c405f.
    1. Wu CC, Yeh DC, Lin MC, Liu TJ, P’eng FK. Prospective randomized trial of systemic antibiotics in patients undergoing liver resection. Br J Surg. 1998;85:489–493. doi: 10.1046/j.1365-2168.1998.00606.x.
    1. Laurent C, Sa Cunha A, Couderc P, Rullier E, Saric J. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg. 2003;90:1131–1136. doi: 10.1002/bjs.4202.
    1. Schiesser M, Chen JWC, Maddern GJ, Padbury RTA. Perioperative morbidity affects long-term survival in patients following liver resection for colorectal metastases. J Gastrointest Surg. 2008;12:1054–1060. doi: 10.1007/s11605-007-0438-y.
    1. Chok KS, Ng KK, Poon RT, Lo CM, Fan ST. Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg. 2009;96:81–87. doi: 10.1002/bjs.6358.
    1. Kaibori M, Ishizaki M, Matsui K, Kwon A-H. Postoperative infectious and non-infectious complications after hepatectomy for hepatocellular carcinoma. Hepatogastroenterology. 2011;58:1747–1756.
    1. Togo S, Tanaka K, Matsuo K, Nagano Y, Ueda M, Morioka D, Endo I, Shimada H. Duration of antimicrobial prophylaxis in patients undergoing hepatectomy: a prospective randomized controlled trial using flomoxef. J Antimicrob Chemother. 2007;59:964–970. doi: 10.1093/jac/dkm028.
    1. Hiramatsu K, Nagino M, Kamiya J, Kondo S, Kanai M, Miyachi M, Uesaka K, Mizuno S, Nimura Y. A new method to prevent wound infection: a controlled clinical trial in patients with combined liver and bile duct resection. Langenbecks Arch Surg. 1998;383:437–441. doi: 10.1007/s004230050156.
    1. Kanazawa H, Nagino M, Kamiya S, Komatsu S, Mayumi T, Takagi K, Asahara T, Nomoto K, Tanaka R, Nimura Y. Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg. 2005;390:104–113. doi: 10.1007/s00423-004-0536-1.
    1. Sugawara G, Nagino M, Nishio H, Ebata T, Takagi K, Asahara T, Nomoto K, Nimura Y. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg. 2006;244:706–714. doi: 10.1097/01.sla.0000219039.20924.88.
    1. Wiezer MJ, Meijer C, Sietses C, Prins HA, Cuesta MA, Beelen RH, Meijer S, van Leeuwen PA. Bactericidal/permeability-increasing protein preserves leukocyte functions after major liver resection. Ann Surg. 2000;232:208–215. doi: 10.1097/00000658-200008000-00010.
    1. Gurusamy KS, Naik P, Davidson BR. Methods of decreasing infection to improve outcomes after liver resections. Cochrane Database Syst Rev. 2011;11:CD006933.
    1. Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology. 2002;122:1763–1770. doi: 10.1053/gast.2002.33587.
    1. Zheng Y, Li F, Qi B, Luo B, Sun H. Application of perioperative immunonutrition for gastrointestinal surgery: a meta-analysis of randomized controlled trials. Asia Pac J Clin Nutr. 2007;16:253–257.
    1. Senkal M, Zumtobel V, Bauer KH, Marpe B, Wolfram G, Frei A, Eickhoff U, Kemen M. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg. 1999;134:1309–16. doi: 10.1001/archsurg.134.12.1309.
    1. Braga M, Gianotti L, Radaelli G, Vignali A, Mari G, Gentilini O, Di Carlo V. Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. Arch Surg. 1999;134:428–33. doi: 10.1001/archsurg.134.4.428.
    1. Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg. 2004;240:205–213. doi: 10.1097/.
    1. Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L, Fan ST, Yokoyama Y, Crawford M, Makuuchi M, Christophi C, Banting S, Brooke-Smith M, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey J-N, Greig P, Rees M, Nimura Y, Figueras J, DeMatteo RP, Büchler MW, Weitz J. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery. 2011;149:680–8. doi: 10.1016/j.surg.2010.12.002.
    1. Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, Koch M, Makuuchi M, Dematteo RP, Christophi C, Banting S, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey J-N, Greig P, Rees M, Yokoyama Y, Fan ST, Nimura Y, Figueras J, Capussotti L, Büchler MW, Weitz J. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS) Surgery. 2011;149:713–24. doi: 10.1016/j.surg.2010.10.001.
    1. Rahbari NN, Garden OJ, Padbury R, Maddern G, Koch M, Hugh TJ, Fan ST, Nimura Y, Figueras J, Vauthey J-N, Rees M, Adam R, Dematteo RP, Greig P, Usatoff V, Banting S, Nagino M, Capussotti L, Yokoyama Y, Brooke-Smith M, Crawford M, Christophi C, Makuuchi M, Büchler MW, Weitz J. Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS) HPB (Oxford) 2011;13:528–35. doi: 10.1111/j.1477-2574.2011.00319.x.
    1. Schulz KF, Altman DG, Moher D. CONSORT, Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;2010(340):c332–c332. doi: 10.1136/bmj.c332.
    1. Correia MIT, Campos ACL. Prevalence of hospital malnutrition in Latin America. Nutrition. 2003;19:823–825. doi: 10.1016/S0899-9007(03)00168-0.
    1. Edington J, Boorman J, Durrant ER, Perkins A, Giffin CV, James R, Thomson JM, Oldroyd JC, Smith JC, Torrance AD, Blackshaw V, Green S, Hill CJ, Berry C, McKenzie C, Vicca N, Ward JE, Coles SJ. Prevalence of malnutrition on admission to four hospitals in England. The Malnutrition Prevalence Group. Clin Nutr. 2000;19:191–5. doi: 10.1054/clnu.1999.0121.
    1. Rasmussen HH, Kondrup J, Staun M, Ladefoged K, Kristensen H, Wengler A. Prevalence of patients at nutritional risk in Danish hospitals. Clin Nutr. 2004;23:1009–1015. doi: 10.1016/j.clnu.2004.01.001.
    1. Spiekerman AM, Rudolph RA, Bernstein LH. Determination of malnutrition in hospitalized patients with the use of a group-based reference. Arch Pathol Lab Med. 1993;117:184–186.
    1. Neithercut WD, Smith AD, McAllister J, La Ferla G. Nutritional survey of patients in a general surgical ward: is there an effective predictor of malnutrition? J Clin Pathol. 1987;40:803–7. doi: 10.1136/jcp.40.7.803.
    1. Larsson J, Akerlind I, Permerth J, Hörnqvist JO. The relation between nutritional state and quality of life in surgical patients. Eur J Surg. 1994;160:329–334.
    1. McWhirter J, Pennington C. Incidence and recognition of malnutrition in hospital J. P. McWhirter and C. R. Pennington. BMJ. 1994;308:945–8. doi: 10.1136/bmj.308.6934.945.
    1. Corish CA, Kennedy NP. Review article protein ± energy undernutrition in hospital in-patients. Br J Nutr. 2000;83:575–591. doi: 10.1017/S000711450000074X.
    1. Spiro A, Baldwin C, Patterson A, Thomas J, Andreyev HJN. The views and practice of oncologists towards nutritional support in patients receiving chemotherapy. Br J Cancer. 2006;95:431–434. doi: 10.1038/sj.bjc.6603280.
    1. Alves A, Panis Y, Mathieu P, Mantion G, Kwiatkowski F, Slim K. Postoperative mortality and morbidity in French patients undergoing colorectal surgery: results of a prospective multicenter study. Arch Surg. 2005;140:278–283. doi: 10.1001/archsurg.140.3.278.
    1. Malone DL, Genuit T, Tracy JK, Gannon C, Napolitano LM. Surgical site infections: reanalysis of risk factors. J Surg Res. 2002;103:89–95. doi: 10.1006/jsre.2001.6343.
    1. Peng PD, van Vledder MG, Tsai S, de Jong MC, Makary M, Ng J, Edil BH, Wolfgang CL, Schulick RD, Choti MA, Kamel I, Pawlik TM. Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB (Oxford) 2011;13:439–46. doi: 10.1111/j.1477-2574.2011.00301.x.
    1. Slim K, Panis Y, Alves A, Kwiatkowski F, Mathieu P, Mantion G. Predicting postoperative mortality in patients undergoing colorectal surgery. World J Surg. 2006;30:100–106. doi: 10.1007/s00268-005-0081-2.
    1. Englesbe M, Patel S, He K. Sarcopenia and post-liver transplant mortality. J Am Coll Surg. 2010;211(January 2010):271–278. doi: 10.1016/j.jamcollsurg.2010.03.039.
    1. Elia M. Nutrition and health economics. Nutrition. 2006;22:576–8. doi: 10.1016/j.nut.2006.01.005.
    1. Heithoff KA, Cuffel BJ, Kennedy S, Peters J. The association between body mass and health care expenditures. Clin Ther. 1997;19:811–20. doi: 10.1016/S0149-2918(97)80104-X.
    1. Wu G-H, Liu Z-H, Wu Z-H, Wu Z-G. Perioperative artificial nutrition in malnourished gastrointestinal cancer patients. World J Gastroenterol. 2006;12:2441–4.
    1. Elia M, Van Bokhorst-de van der Schueren MA, Garvey J, Goedhart A, Lundholm K, Nitenberg G, Stratton RJ. Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int J Oncol. 2006;28:5–23.
    1. Potenza MA, Nacci C, Mitolo-Chieppa D. Immunoregulatory effects of L-arginine and therapeutical implications. Curr Drug Targets Immune Endocr Metabol Disord. 2001;1:67–77. doi: 10.2174/1568008013341811.
    1. Ochoa JB, Makarenkova V, Bansal V. A rational use of immune enhancing diets: when should we use dietary arginine supplementation? Nutr Clin Pract. 2004;19:216–25. doi: 10.1177/0115426504019003216.
    1. Reynolds JV, Daly JM, Shou J, Sigal R, Ziegler MM, Naji A. Immunologic effects of arginine supplementation in tumor-bearing and non-tumor-bearing hosts. Ann Surg. 1990;211:202–210. doi: 10.1097/00000658-199002000-00013.
    1. Chattopadhyay P, Shukla G, Wahi AK. Protective effect of L-arginine against necrosis and apoptosis induced by experimental ischemic and reperfusion in Rat liver. J Gastroenterol. 2009;15:156–162.
    1. Kew S, Mesa MD, Tricon S, Buckley R, Minihane AM, Yaqoob P. Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans. Am J Clin Nutr. 2004;79:674–81.
    1. Suzuki D, Furukawa K, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Miyazaki M. Effects of perioperative immunonutrition on cell-mediated immunity, T helper type 1 (Th1)/Th2 differentiation, and Th17 response after pancreaticoduodenectomy. Surgery. 2010;148:573–81. doi: 10.1016/j.surg.2010.01.017.
    1. Grimble GK, Westwood OM. Nucleotides as immunomodulators in clinical nutrition. Curr Opin Clin Nutr Metab Care. 2001;4:57–64. doi: 10.1097/00075197-200101000-00011.
    1. Cerantola Y, Hübner M, Grass F, Demartines N, Schäfer M. Immunonutrition in gastrointestinal surgery. Br J Surg. 2011;98:37–48. doi: 10.1002/bjs.7273.
    1. Bozzetti F, Gianotti L, Braga M, Di Carlo V, Mariani L. Postoperative complications in gastrointestinal cancer patients: the joint role of the nutritional status and the nutritional support. Clin Nutr. 2007;26:698–709. doi: 10.1016/j.clnu.2007.06.009.
    1. Mikagi K, Kawahara R, Kinoshita H, Aoyagi S. Effect of preoperative immunonutrition in patients undergoing hepatectomy; a randomized controlled trial. Kurume Med J. 2011;58:1–8. doi: 10.2739/kurumemedj.58.1.
    1. Fan ST, Lo CM, Lai EC, Chu KM, Liu CL, Wong J. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med. 1994;331:1547–52. doi: 10.1056/NEJM199412083312303.
    1. Okabayashi T, Iyoki M, Sugimoto T, Kobayashi M, Hanazaki K. Oral supplementation with carbohydrate- and branched-chain amino acid-enriched nutrients improves postoperative quality of life in patients undergoing hepatic resection. Amino Acids. 2011;40:1213–20. doi: 10.1007/s00726-010-0748-3.
Pre-publication history
    1. The pre-publication history for this paper can be accessed here:

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera